John G O'Shea1. Show Affiliations » 1. Newcastle Eye Centre, Newcastle, NSW, Australia and School of Medicine and Public Health, University of Newcastle, NSW, Australia. jgoshea@gmail.com
Abstract
Entities: Chemical
Mesh： See more » Angiogenesis Inhibitors/therapeutic useAntibodies, Monoclonal, Humanized/therapeutic useBevacizumabCost-Benefit AnalysisDrug CostsHumansMacular Degeneration/drug therapyRanibizumabVascular Endothelial Growth Factor A/antagonists & inhibitors
Substances： See more » Angiogenesis InhibitorsAntibodies, Monoclonal, HumanizedVascular Endothelial Growth Factor ABevacizumabRanibizumab
Year: 2012 PMID： 22672003 DOI： 10.1111/j.1444-0938.2012.00736.x
Source DB: PubMed Journal: Clin Exp Optom ISSN： 0816-4622 Impact factor: 2.742